热门资讯> 正文
Nkarta,Nuvation Bio,冠状动脉的增长
2024-03-25 22:00
- Gainers: Landos Biopharma (LABP) +176%.
- Altamira Therapeutics (CYTO) +86%.
- Nkarta (NKTX) +22%.
- Flora Growth (FLGC) +21%.
- Sagimet Biosciences (SGMT) +19%.
- Losers: Nuvation Bio (NUVB) -23%.
- Autonomix Medical (AMIX) -14%.
- Leafly Holdings (LFLY) -12%.
- Invivyd (IVVD) -12%.
- Canopy Growth (CGC) -10%.
- S&P 500 Health Care Sector +0.1% to $1,699.17. Health Care Equipment & Services +0.2% to $2,262.08. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.5% to $1,105.36.
More on Health Care Select Sector SPDR
- XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance
- Healthcare In 2024: Navigating The Biopharma Bull Run
- Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end
- Waters, Moderna most shorted stocks in S&P 500 health sector till Jan-end
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。